EAM

Exos Asset Management’s SAB Biotherapeutics SABS Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-35,264	Closed	-$355K	–	377
2021 Q3	$355K	Buy	35,264 +10,306	+41%	+$104K	0.19%	153
2021 Q2	$249K	Sell	24,958 -42	-0.2%	-$419	0.13%	242
2021 Q1	$246K	Buy	+25,000	New	+$246K	0.19%	180